<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30063890</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>12</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-2933</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>60</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical biochemistry</Title>                <ISOAbbreviation>Clin. Biochem.</ISOAbbreviation>            </Journal>            <ArticleTitle>A comprehensive clinicopathological evaluation of the differential expression of microRNA-331 in breast tumors and its diagnostic significance.</ArticleTitle>            <Pagination>                <MedlinePgn>24-32</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0009-9120(18)30339-4</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinbiochem.2018.07.008</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">MicroRNA-331 (miR-331) has shown regulatory activity against several genes whose expression has been claimed to be deregulated in breast tumors, including that of epidermal growth factor receptor 2 (HER2). Herein, the clinical value of miR-331 expression was investigated by analyzing its levels in breast benign and malignant tumors.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">The expression levels of miR-331 were quantified via real-time PCR in 130 malignant and 66 benign breast tissue specimens collected after surgical resection of primary tumors. The generated data were analyzed by applying several statistical tests in order to examine the relationship of miR-331 expression with various established clinicopathological features and survival data of patients.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Our data showed that miR-331 was overexpressed in malignant breast tumors compared to their benign counterparts both overall (P = 0.026) and individually when the subgroups of fibroadenoma and invasive ductal carcinoma were analyzed with each other (P = 0.001). ROC curve analysis confirmed the diagnostic value of these variations, providing an AUC value equal to 0.597 (P = 0.026) and 0.663 (P = 0.001), respectively. Furthermore, miR-331 levels were elevated (P = 0.026) in ductal cancerous specimens compared to the lobular ones but failed to correlate with other clinicopathological features or survival data of the breast cancer patients.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results provide evidence that miR-331 levels might provide valuable information regarding the differential diagnosis of benign and malignant breast tumors but present no prognostic value for breast cancer.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Papadopoulos</LastName>                    <ForeName>Emmanuel I</ForeName>                    <Initials>EI</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Papachristopoulou</LastName>                    <ForeName>Georgia</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, Athens, Greece; First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece; Department of Pathology, &quot;Saint Savvas&quot; Cancer Hospital of Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ardavanis</LastName>                    <ForeName>Alexandros</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>First Department of Medical Oncology, &quot;Saint Savvas&quot; Cancer Hospital of Athens, 171 Alexandras Ave., 11522 Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Scorilas</LastName>                    <ForeName>Andreas</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, Athens, Greece. Electronic address: ascorilas@biol.uoa.gr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>29</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Biochem</MedlineTA>            <NlmUniqueID>0133660</NlmUniqueID>            <ISSNLinking>0009-9120</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Biomarker</Keyword>            <Keyword MajorTopicYN="N">Breast benign tumors</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Ductal adenocarcinoma</Keyword>            <Keyword MajorTopicYN="N">Lobular adenocarcinoma</Keyword>            <Keyword MajorTopicYN="N">microRNA-331</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30063890</ArticleId>            <ArticleId IdType="pii">S0009-9120(18)30339-4</ArticleId>            <ArticleId IdType="doi">10.1016/j.clinbiochem.2018.07.008</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>